Cargando…

2402. Evaluating Clinical Outcomes of Adjunctive Beta-Lactam Use in Vancomycin-Resistant Enterococcus Infective Endocarditis

BACKGROUND: Vancomycin resistant enterococcus (VRE) infective endocarditis (IE) is associated with poor outcomes. There are limited data to guide the antimicrobial choice and duration of therapy. Several in vitro and limited clinical studies demonstrate the synergistic effect of β-lactams with other...

Descripción completa

Detalles Bibliográficos
Autores principales:	Khan, Ebrahim H, Yetmar, Zachary A, Abu Saleh, Omar M, Mahmood, Maryam
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2023
Materias:	Abstract
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10679231/ http://dx.doi.org/10.1093/ofid/ofad500.2022

Ejemplares similares

1611. Evaluating Clinical Outcomes and Efficacy of Daptomycin in Combination with a Beta-Lactam for the Treatment of Vancomycin-Resistant Enterococcus (VRE) Bacteremia
por: Irusta, Nerea, et al.
Publicado: (2020)

Successful Treatment of Vancomycin-Resistant Enterococcus species Bone and Joint Infection with Daptomycin Plus Beta Lactam Agents
por: La, Yeon Ju, et al.
Publicado: (2022)

162. Assessment of Beta-lactam Allergies as Rationale for Receipt of Vancomycin for Surgical Prophylaxis
por: Tucker, Kendall J, et al.
Publicado: (2020)

2402. Daptomycin Pulmonary Eosinophilia: Review of Cases and New Hyperacute Syndromic Presentation
por: West, Katelyn, et al.
Publicado: (2018)

2402. Clinical Outcomes Associated with an Emerging Clostridioides difficile Ribotype 255 in Texas
por: Gonzales-Luna, Anne J, et al.
Publicado: (2019)

1294. A survey on Vancomycin and Beta Lactams usage in critical care settings in Makkah, Kingdom of Saudi Arabia
por: Hanif, Abdul-Hasseb, et al.
Publicado: (2020)

1462. Analysis of Clindamycin and Vancomycin Use and Reported Beta Lactam Allergy in Procedural Antimicrobial Prophylaxis
por: Veach, Lisa A, et al.
Publicado: (2023)

2676. Effect of β-Lactam Allergy on Appropriateness of Antibiotic Use in Patients with Febrile Neutropenia
por: Yetmar, Zachary A, et al.
Publicado: (2019)

Vancomycin-Resistant Enterococcus Endocarditis Complicated by Splenic Infarction and Embolic Stroke
por: Khatri, Shivam, et al.
Publicado: (2023)

1066. Adjuvant β-Lactam Therapy Combined with Vancomycin for Methicillin-Resistant Staphylococcus aureus (MRSA) Bacteremia: Does β-Lactam class Matter?
por: Dilworth, Thomas J, et al.
Publicado: (2018)

Predictors of Vancomycin-Resistant Enterococcus (VRE) Bacteremia in Ontario, Canada
por: Johnstone, Jennie, et al.
Publicado: (2017)

Prolonged Use of Oritavancin for Vancomycin-Resistant Enterococcus faecium Prosthetic Valve Endocarditis
por: Johnson, Jennifer A., et al.
Publicado: (2015)

1546. Efficacy of Daptomycin Combinations Against Daptomycin-Resistant Enterococcus faecium Differs by β-lactam
por: Kebriaei, Razieh, et al.
Publicado: (2019)

A retrospective clinical comparison of daptomycin vs daptomycin and a beta-lactam antibiotic for treating vancomycin-resistant Enterococcus faecium bloodstream infections
por: Chuang, Yu-Chung, et al.
Publicado: (2018)

Efficacy of vancomycin-beta-lactam combinations against heterogeneously vancomycin-resistant Staphylococcus aureus (hetero-VRSA).
por: Kim, Yeon Sook, et al.
Publicado: (2003)

Novel double beta-lactam therapy for Granulicatella adiacens infective endocarditis
por: Khan, S., et al.
Publicado: (2021)

1805. Safety Outcomes Following Beta-Lactam use in Patients with a Documented Beta-Lactam Allergy
por: Rampersad, Daniel, et al.
Publicado: (2022)

757 Comparison of Nephrotoxicity in Outpatient Parenteral Antimicrobial Therapy (OPAT) Patients Receiving Beta-lactams or Vancomycin
por: Streifel, Amber, et al.
Publicado: (2014)

649. The Clinical Significance of Sequence Type 17 of Vancomycin-Resistant Enterococcus faecium
por: Kim, Si-Ho, et al.
Publicado: (2018)

1772. Vancomycin-Resistant Enterococcus Alters the Gastrointestinal Microbiome in Critically Ill Patients
por: Cuaresma, Edward, et al.
Publicado: (2018)

318. Beta-lactam Therapeutic Drug Monitoring Improves Attainment of Target Drug Levels in Critically Ill Patients
por: Ausman, Sara, et al.
Publicado: (2023)

Homologous Recombination within Large Chromosomal Regions Facilitates Acquisition of β-Lactam and Vancomycin Resistance in Enterococcus faecium
por: García-Solache, Mónica, et al.
Publicado: (2016)

Vancomycin (VAN) Combinations with Β-Lactams (BLs) against Methicillin-Resistant Staphylococcus aureus (MRSA), Heterogeneous Intermediate-Level Resistance to Vancomycin (hVISA) and Vancomycin-Intermediate Staphylococcus aureus (VISA)
por: Tran, Kieu-Nhi, et al.
Publicado: (2017)

575. Evaluation of Risk Factors and Clinical Outcomes of Patients with Vancomycin-Resistant Enterococcus Infections
por: Chauhan, Gauri, et al.
Publicado: (2019)

1527. Clinical Variables Associated with Vancomycin Resistance in Children with Bacteremia Due to Enterococcus spp.
por: Jimena, Carla, et al.
Publicado: (2019)

1559. Ertapenem Plus Ceftriaxone or Ceftaroline Dual Β-Lactam Combination for Enterococcus faecalis
por: Cusumano, Jaclyn A, et al.
Publicado: (2019)

Comparative Effectiveness of Vancomycin vs. Metronidazole in Mild Clostridium difficile Infections, and Potential Impact on Subsequent Vancomycin-Resistant Enterococcus (VRE) Isolation
por: Youngster, Ilan, et al.
Publicado: (2017)

1399. Efficacy of Daptomycin Combination with β-Lactams for Daptomycin-resistant Enterococcus faecium Harboring LiaSR Substitutions
por: Kebriaei, Razieh, et al.
Publicado: (2018)

831. Majocchi’s Granuloma – A Single Institution Retrospective Review
por: Montagnon, Carmen M, et al.
Publicado: (2023)

2441. Outcomes of Patients With Vancomycin-Resistant Enterococcus Blood Stream Infections (BSI) Treated With Daptomycin
por: Shimose, Luis A, et al.
Publicado: (2018)

2444. Incidence of Daptomycin Toxicity Among Patients With Vancomycin-Resistant Enterococcus Blood Stream Infections
por: Rios, Maria X Bueno, et al.
Publicado: (2018)

1255. First Outbreak Due to Vancomycin-Resistant Enterococcus Epidemic Clone ST796 in Europe
por: Wassilew, Nasstasja, et al.
Publicado: (2018)

P23 Rates, treatment and outcomes of vancomycin-resistant Enterococcus faecium bacteraemia at Addenbrooke’s Hospital
por: Barnes, David, et al.
Publicado: (2023)

779. PIDS Featured Oral Abstract: High Beta Lactam Exposure in Neonates with Bloodstream Infection Associated with Intestinal Dysbiosis and Enterococcus spp. Abundance in the Gut Microbiome
por: Hendricks, Hope, et al.
Publicado: (2022)

733 Vancomycin-Resistant Enterococcus (VRE) faecium Bloodstream Infections and Mortality
por: Suleyman, Geehan, et al.
Publicado: (2014)

738. Outcomes of Ceftriaxone Versus Antistaphylococcal Penicillins or Cefazolin for Definitive Therapy of Methicillin-susceptible Staphylococcus aureus Bacteremia
por: Khodadadi, Ryan B, et al.
Publicado: (2022)

1779. Trends in Anaplasmosis Over the Past Decade: A Review of Clinical Features, Laboratory Data and Outcomes
por: Katragadda, Silpita, et al.
Publicado: (2023)

243. A Laboratory Intervention to Enhance Recognition of Bacteremia in Patients with Staphylococcus aureus Bacteriuria
por: Vaillant, James J, et al.
Publicado: (2023)

743. Implementation of Beta-Lactam Therapeutic Drug Monitoring Programs in the Critically Ill: A Multicenter Mixed-Methods Study
por: Ausman, Sara, et al.
Publicado: (2022)

1250. Development of Linezolid and Daptomycin Resistance in Vancomycin Resistant Enterococcus faecium (VRE) during prolonged treatment for Intraabdominal Abscess
por: Al-Heeti, Omar, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_e5j9dqqcck1hp1e8hi4mo1j1lg